(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

V-OVS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

V-OVS

ST13

US500000088800804

Class

5, 10, 39, 42

Filing

88800804

Registration

7008742

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

04/21/2023

Trademark type

Word

Nice classes

5, 10, 39, 42

Filing date

02/18/2020

Registration date

03/28/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/28/2023

Last transaction

04/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

99

Owner location

Ravensburg, DE

Examiner

GILBERT, REBECCA L

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Vetter Pharma-Fertigung GmbH & Co. KG

Representatives

M. Scott Alprin ALPRIN LAW OFFICES, P.C.

Technical classification

Nice Classes

Class 5Class 10Class 39Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and medicinesorally administrable solutionsinjectable solutionssolids and semisolids capable of being dissolved in liquids and solventspowders in ready-to-use form or capable of reconstitutionall for use in the treatment of infectionscancerdepressionheart diseasevascular diseaseintestinal disorderlung and bronchial disfunctionliver disfunctionoral and laryngeal diseaseoptical and cranial disorders; eyedrops; solutions for contact lenses; pharmaceutical preparations for use in the treatment of infectionscancerdepressionheart diseasevascular diseaseintestinal disorderlung and bronchial disfunctionliver disfunctionoral and laryngeal diseaseoptical and cranial disorderssold in prefilled syringes; syringe components of syringes sold prefilled with pharmaceutical preparations for use in the treatment of infectionscancerdepressionheart diseasevascular diseaseintestinal disorderlung and bronchial disfunctionliver disfunctionoral and laryngeal diseaseoptical and cranial disordersalcoholiodinesterilizing agents and cleaning solutions for medical purposes; premoistened cotton swabs for medical purposes; adhesive bandages; surgical bandages; bandages for skin wounds

Class 10

Medical injection devicesinjection syringespen-type injectorsautoinjectorsdisposable and reusable syringessyringe holder attachments to aid in holding injection needles perpendicular to the skindouble or multi-chamber syringes and injector pens; accessories for medical injection devices and medical containerssyringessyringe closures and partial syringe closures; disposable cannulasblood collection vials for medical use; elastic bandagesbandages for anatomical jointsorthopedic support bandages and compression bandages

Class 39

Asepticsterile bottling of substancespharmaceuticalchemical and biological preparations and medicines

Class 42

Microbiological laboratory testing and analysischemical laboratory researchall services for others

Publications

History of USPTO decisions and trademark events.

45 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

03/28/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/10/2023

PUBO

PUBLISHED FOR OPPOSITION

01/10/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/21/2022

RPUB

NOA CANCELLED; REPUBLICATION REQUIRED

12/02/2022

IUCN

NOTICE OF ALLOWANCE CANCELLED

12/02/2022

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

12/01/2022

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

12/01/2022

APET

ASSIGNED TO PETITION STAFF

11/29/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/16/2022

EX3G

SOU EXTENSION 3 GRANTED

11/14/2022

EXT3

SOU EXTENSION 3 FILED

11/14/2022

EEXT

SOU TEAS EXTENSION RECEIVED

11/14/2022

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

11/14/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/19/2022

EX2G

SOU EXTENSION 2 GRANTED

05/17/2022

EXT2

SOU EXTENSION 2 FILED

05/17/2022

EEXT

SOU TEAS EXTENSION RECEIVED

05/17/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/12/2021

EX1G

SOU EXTENSION 1 GRANTED

11/10/2021

EXT1

SOU EXTENSION 1 FILED

11/10/2021

EEXT

SOU TEAS EXTENSION RECEIVED

11/10/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/18/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/23/2021

PUBO

PUBLISHED FOR OPPOSITION

03/23/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/17/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

02/17/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/17/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

02/17/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/17/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/12/2021

GNSL

LETTER OF SUSPENSION E-MAILED

02/12/2021

CNSL

SUSPENSION LETTER WRITTEN

02/12/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/10/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/10/2021

ALIE

ASSIGNED TO LIE

02/09/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/06/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/08/2020

GNRT

NON-FINAL ACTION E-MAILED

05/08/2020

CNRT

NON-FINAL ACTION WRITTEN

05/08/2020

DOCK

ASSIGNED TO EXAMINER

05/07/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/22/2020

NWAP

NEW APPLICATION ENTERED

02/21/2020

Continuous trademark protection

Get notified about every new filing that threatens V-OVS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.